GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » Revenue

Kangji Medical Holdings (HKSE:09997) Revenue : HK$1,013 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings Revenue?

Kangji Medical Holdings's revenue for the six months ended in Dec. 2023 was HK$571 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,013 Mil. Kangji Medical Holdings's Revenue per Share for the six months ended in Dec. 2023 was HK$0.49. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.86.

During the past 12 months, the average Revenue per Share Growth Rate of Kangji Medical Holdings was 18.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 7 years, Kangji Medical Holdings's highest 3-Year average Revenue per Share Growth Rate was 39.00% per year. The lowest was 11.20% per year. And the median was 23.20% per year.


Kangji Medical Holdings Revenue Historical Data

The historical data trend for Kangji Medical Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings Revenue Chart

Kangji Medical Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 560.23 606.34 845.21 878.15 1,012.86

Kangji Medical Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 455.67 389.55 507.04 441.44 571.43

Competitive Comparison of Kangji Medical Holdings's Revenue

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangji Medical Holdings's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's Revenue falls into.



Kangji Medical Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1,013 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kangji Medical Holdings  (HKSE:09997) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Kangji Medical Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangji Medical Holdings (HKSE:09997) Business Description

Traded in Other Exchanges
Address
No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.
Executives
Butterfield Trust (asia) Limited 2301 Trustee
Fortune Spring Zm Aa Limited 2101 Beneficial owner
Yg Aa Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2201 Interest of corporation controlled by you
Zhong Ming 2501 Other
Fortune Spring Yg B Limited 2101 Beneficial owner
Shentu Yinguang 2501 Other
Fortune Spring Zm B Limited 2101 Beneficial owner
Credit Suisse Trust Limited 2201 Interest of corporation controlled by you
Bonderman David 2201 Interest of corporation controlled by you
Coulter James George 2201 Interest of corporation controlled by you
Keyhole Holding Limited 2101 Beneficial owner
Tpg Asia Genpar Vii Advisors, Inc. 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Group Holdings (sbs) Advisors, Inc. 2201 Interest of corporation controlled by you

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines